Quantitative real-time (qRT) PCR for NME2 showed significantly reduced transcript level in advanced stage tumor samples (n = 44, ∼1.7-fold depletion; equivalent to 41% decrease, P < 0.003; Figure 2B) confirming the trend observed in tumor transcriptome meta-analyses. This evidence concerns the gene NME2 and neoplasm.